For pharmacy chains, behind-the-counter naloxone dispensing entails working closely with state regulators to ensure compliance and collaborating with prescribers.
The Coalition to Stop Opioid Overdose is backed in part by three pharmaceutical companies, and it aims to advocate for opioid-related legislation and adequate federal funding.
With gaps in prescription drug monitoring databases potentially being exploited, the Pharmacy Home Program for Anthem health plans limits high-risk members’ drug coverage to a single location.
View issues archive
Get the Digital Edition